Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Combination therapy with lentinan improves outcomes in patients with esophageal carcinoma.

Wang JL, Bi Z, Zou JW, Gu XM.

Mol Med Rep. 2012 Mar;5(3):745-8. doi: 10.3892/mmr.2011.718. Epub 2011 Dec 19.

PMID:
22200763
3.

Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy.

Pusztai L, Mendoza TR, Reuben JM, Martinez MM, Willey JS, Lara J, Syed A, Fritsche HA, Bruera E, Booser D, Valero V, Arun B, Ibrahim N, Rivera E, Royce M, Cleeland CS, Hortobagyi GN.

Cytokine. 2004 Feb 7;25(3):94-102.

PMID:
14698135
4.

Predominance of TH1 response in tumor-bearing mice and cancer patients treated with AS101.

Sredni B, Tichler T, Shani A, Catane R, Kaufman B, Strassmann G, Albeck M, Kalechman Y.

J Natl Cancer Inst. 1996 Sep 18;88(18):1276-84.

PMID:
8797767
5.

[Postoperative Th1 and Th2 type cytokine changes in patients with esophageal squamous cell carcinoma and their clinical significance].

Wei YC, Hu FB, Shen Y, Xu LH, Lin LS.

Di Yi Jun Yi Da Xue Xue Bao. 2004 Nov;24(11):1271-3. Chinese.

6.

Efficacy of orally administered superfine dispersed lentinan (beta-1,3-glucan) for the treatment of advanced colorectal cancer.

Hazama S, Watanabe S, Ohashi M, Yagi M, Suzuki M, Matsuda K, Yamamoto T, Suga Y, Suga T, Nakazawa S, Oka M.

Anticancer Res. 2009 Jul;29(7):2611-7.

7.

Serum levels of the pro-inflammatory cytokine interleukin-12 and the anti-inflammatory cytokine interleukin-10 in patients with psoriasis treated by the Goeckerman regimen.

Borska L, Andrys C, Krejsek J, Hamakova K, Kremlacek J, Ettler K, Fiala Z.

Int J Dermatol. 2008 Aug;47(8):800-5. doi: 10.1111/j.1365-4632.2008.03677.x.

PMID:
18717859
8.

Agrocybe aegerita polysaccharide combined with chemotherapy improves tumor necrosis factor-α and interferon-γ levels in rat esophageal carcinoma.

Ji Y, Zheng MF, Ye SG, Wu XB, Chen JY.

Dis Esophagus. 2013 Nov-Dec;26(8):859-63. doi: 10.1111/j.1442-2050.2012.01397.x. Epub 2012 Sep 4.

PMID:
22947091
9.

Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC.

Yang P, Liang M, Zhang Y, Shen B.

Adv Ther. 2008 Aug;25(8):787-94. doi: 10.1007/s12325-008-0079-x.

PMID:
18670743
10.

Subcutaneous interleukin-2 in combination with medroxyprogesterone acetate and antioxidants in advanced cancer responders to previous chemotherapy: phase II study evaluating clinical, quality of life, and laboratory parameters.

Mantovani G, Madeddu C, Gramignano G, Lusso MR, Mocci M, Massa E, Ferreli L, Astara G, Macciò A, Serpe R.

J Exp Ther Oncol. 2003 Jul-Aug;3(4):205-19.

PMID:
14567291
11.

[Effects of lentinan in advanced or recurrent cases of gastric, colorectal, and breast cancer].

Taguchi T.

Gan To Kagaku Ryoho. 1983 Feb;10(2 Pt 2):387-93. Japanese.

PMID:
6349538
12.

[TS-1/CDDP/Lentinan combination chemotherapy for inoperable advanced gastric cancer].

Nagahashi S, Suzuki H, Nishiwaki M, Okuda K, Kurosawa Y, Terada S, Sugihara T, Andou K, Hibi T.

Gan To Kagaku Ryoho. 2004 Nov;31(12):1999-2003. Japanese.

PMID:
15570928
14.

The effect of lentinan combination therapy for unresectable advanced gastric cancer.

Higashi D, Seki K, Ishibashi Y, Egawa Y, Koga M, Sasaki T, Hirano K, Mikami K, Futami K, Maekawa T, Sudo M.

Anticancer Res. 2012 Jun;32(6):2365-8.

PMID:
22641676
15.

[A comparative clinical trial with tegafur plus lentinan treatment at two different doses in advanced cancer].

Wada T, Nishide T, Hatayama K, Chang SW, Tatsuta M, Yasutomi M.

Gan To Kagaku Ryoho. 1987 Aug;14(8):2509-12. Japanese.

PMID:
3113339
16.
17.

The effect of tramadol on serum cytokine response in patients undergoing pulmonary lobectomy.

Wang G, Weng Y, Ishiguro Y, Sakamoto H, Morita S.

J Clin Anesth. 2005 Sep;17(6):444-50.

PMID:
16171665
18.

[Results of phase III study of lentinan].

Taguchi T, Furue H, Kimura T, Kondo T, Hattori T, Itoh I, Ogawa N.

Gan To Kagaku Ryoho. 1985 Feb;12(2):366-78. Japanese.

PMID:
3918510
19.

[Effect of lentinan for advanced prostate carcinoma].

Tari K, Satake I, Nakagomi K, Ozawa K, Oowada F, Higashi Y, Negishi T, Yamada T, Saito H, Yoshida K.

Hinyokika Kiyo. 1994 Feb;40(2):119-23. Japanese.

20.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110

Supplemental Content

Support Center